In a new study published in the journal ACS Nano, researchers Sangeeta N Bhatia, lead author and PhD candidate Kevin Lin and postdoctoral fellow Gabriel Kwong describe the results of the urine test on laboratory mice.
Blood clots - clumps of platelets and fibrin proteins - can threaten to choke off blood flow and lead to a wide range of serious and sometimes fatal conditions including atherosclerosis and stroke.
Usually, blood clots are a good thing. They form a plug that stops the bleeding after an injury. But sometimes, a clot forms when it really isn't needed, such as when a person sits too long on a long-distance flight and develops "deep-vein thrombosis."
Diagnosing a blood clot, or thrombosis, is tricky, however, and current clinical tests aren't always reliable. Researchers wanted to develop a simple and more reliable way to test for these obstructive blood clots.
More From This Section
They describe development and testing of "synthetic biomarkers" - lab-made materials for detecting what is going on in the body.
They added small pieces of proteins called peptides onto nanomaterials that are similar to those already approved and used in the clinic.
"Our results demonstrate that synthetic biomarkers can be engineered to sense vascular diseases remotely from the urine and may allow applications in point-of-care diagnostics," the researchers said.